• Science & Technology

Citizen Scientists can spot cancer cells like pathologists, so what happens next?

Citizen Scientists are helping our researchers analyse cancer data, but how good are they? We explore the results of a new study to find out. Citizen Scientists are helping our researchers analyse cancer data, but how good are they? We explore the results of a new study to find out.

1 October 2015

• Science & Technology

Stopping cancer’s scrum for survival

Our scientists have discovered that similar to a rugby maul, cancer cells can ward off tumour-killing immune cells through an important cellular signal. Our scientists have discovered that similar to a rugby maul, cancer cells can ward off tumour-killing immune cells through an important cellular signal.

25 September 2015

• Policy & Insight
• Science & Technology

Expert Opinion - treating cancer by exploiting how its DNA is repaired

We spoke to two of our own experts about how they're targeting fundamental repair processes in our cells to tip cancer cells over the edge. We spoke to two of our own experts about how they're targeting fundamental repair processes in our cells to tip cancer cells over the edge.

18 September 2015

• Health & Medicine

Expert Opinion – Professor Peter Johnson on cancer immunotherapy

We quiz our chief clinician, Professor Peter Johnson, to get his take on the history of cancer immunotherapy and where the field is heading. We quiz our chief clinician, Professor Peter Johnson, to get his take on the history of cancer immunotherapy and where the field is heading.

17 September 2015

• Science & Technology
• Health & Medicine

Targeting cancer’s self-defence mechanisms

We often talk about cancer as being a disease caused by mistakes in DNA – the genetic instructions inside all our cells that tell them to make molecules such as proteins. And faulty genes do indeed cause cells to grow out of control, leading to cancer. But it isn’t just the sequence of the DNA that matters, but also how it’s used that’s important. We often talk about cancer as being a disease caused by mistakes in DNA – the genetic instructions inside all our cells that tell them to make molecules such as proteins. And faulty genes do indeed cause cells to grow out of control, leading to cancer. But it isn’t just the sequence of the DNA that matters, but also how it’s used that’s important.

16 September 2015

• Science & Technology

Eye gene acts as ‘partner in crime’ in leukaemia mystery case

Our scientists have solved the mystery of why a gene involved in human eye development may also play a role in an aggressive form of blood cancer. Our scientists have solved the mystery of why a gene involved in human eye development may also play a role in an aggressive form of blood cancer.

14 September 2015

• Health & Medicine

Fishing for cancer cures: our new Cancer Research UK-MedImmune Alliance Laboratory

A droplet of clear liquid in a plastic tube no bigger than a Biro lid may not look that impressive, but it could hold the cancer cures of the future. A droplet of clear liquid in a plastic tube no bigger than a Biro lid may not look that impressive, but it could hold the cancer cures of the future.

11 September 2015

• Science & Technology

A legacy of ground-breaking research

Read the inspiring story of how a generous gift left by a couple in their Will is helping our scientists understand how cancers spread. Read the inspiring story of how a generous gift left by a couple in their Will is helping our scientists understand how cancers spread.

9 September 2015

• Health & Medicine
• Science & Technology

Could aspirin boost cancer immunotherapy?

We explore new research suggesting that aspirin might help boost the cancer-fighting effects of immunotherapy in mice. We explore new research suggesting that aspirin might help boost the cancer-fighting effects of immunotherapy in mice.

3 September 2015

• Science & Technology
• Health & Medicine

Two years on for our pioneering TRACERx lung cancer study

Two years ago we launched a pioneering £15m lung cancer study. Find out what's happened since, through the eyes of Terrence, a patient taking part. Two years ago we launched a pioneering £15m lung cancer study. Find out what's happened since, through the eyes of Terrence, a patient taking part.

2 September 2015